Location, location, location: new insights into O-GalNAc protein glycosylation.

O-GalNAc glycosylation of proteins confers essential structural, protective and signaling roles in eumetazoans. Addition of O-glycans onto proteins is an extremely complex process that regulates both sites of attachment and the types of oligosaccharides added. Twenty distinct polypeptide GalNAc-transferases (GalNAc-Ts) initiate O-glycosylation and fine-tuning their expression provides a mechanism for regulating this action. Recently, a new mode of regulation has emerged where activation of Src kinase selectively redistributes Golgi-localized GalNAc-Ts to the ER. This relocalization results in a strong increase in the density of O-glycan decoration. In this review, we discuss how different mechanisms can regulate the number and the types of O-glycans decorating proteins. In addition, we speculate how Src-dependent relocation of GalNAc-Ts could play an important role in cancerous cellular transformation.

[1]  Y. Ikehara,et al.  Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens. , 1999, Glycobiology.

[2]  Zhenyu Zhang,et al.  Functional Characterization and Expression Analysis of Members of the UDP-GalNAc:Polypeptide N-Acetylgalactosaminyltransferase Family from Drosophila melanogaster* , 2003, Journal of Biological Chemistry.

[3]  L. Tabak,et al.  Glycopeptide-preferring Polypeptide GalNAc Transferase 10 (ppGalNAc T10), Involved in Mucin-type O-Glycosylation, Has a Unique GalNAc-O-Ser/Thr-binding Site in Its Catalytic Domain Not Found in ppGalNAc T1 or T2* , 2009, The Journal of Biological Chemistry.

[4]  R Apweiler,et al.  On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. , 1999, Biochimica et biophysica acta.

[5]  J. Paulson,et al.  Demonstration of an extensive trans-tubular network continuous with the Golgi apparatus stack that may function in glycosylation , 1985, Cell.

[6]  T. Homma,et al.  Core 2-containing O-glycans on CD43 are preferentially expressed in the memory subset of human CD4 T cells. , 1999, International immunology.

[7]  Carolyn R Bertozzi,et al.  The chemistry and biology of mucin-type O-linked glycosylation. , 2005, Bioorganic & medicinal chemistry.

[8]  I. Brockhausen,et al.  The Relative Activities of the C2GnT1 and ST3Gal-I Glycosyltransferases Determine O-Glycan Structure and Expression of a Tumor-associated Epitope on MUC1* , 2001, The Journal of Biological Chemistry.

[9]  R. Hill,et al.  Subcellular localization of the UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-mediated O-glycosylation reaction in the submaxillary gland. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Nakanishi,et al.  Molecular Cloning and Characterization of a Novel UDP-GlcNAc:GalNAc-peptide β1,3-N-Acetylglucosaminyltransferase (β3Gn-T6), an Enzyme Synthesizing the Core 3 Structure of O-Glycans* , 2002, The Journal of Biological Chemistry.

[11]  R. Cummings,et al.  Cloning and Expression of Human Core 1 β1,3-Galactosyltransferase* , 2002, The Journal of Biological Chemistry.

[12]  M. Hollingsworth,et al.  A novel human UDP‐N‐acetyl‐D‐galactosamine:polypeptide N‐acetylgalactosaminyltransferase, GalNAc‐T7, with specificity for partial GalNAc‐glycosylated acceptor substrates , 1999, FEBS letters.

[13]  Marion C Lanteri,et al.  Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death. , 2003, Glycobiology.

[14]  E. Tian,et al.  Recent insights into the biological roles of mucin-type O-glycosylation , 2009, Glycoconjugate Journal.

[15]  T. Gerken,et al.  Conservation of peptide acceptor preferences between Drosophila and mammalian polypeptide-GalNAc transferase ortholog pairs. , 2008, Glycobiology.

[16]  I. Brockhausen,et al.  Detection of glycosyltransferases in the golden hamster (Mesocricetus auratus) oviduct and evidence for the regulation of O-glycan biosynthesis during the estrous cycle. , 2005, Biochimica et biophysica acta.

[17]  B. K. Hayes,et al.  The biosynthesis of oligosaccharides in intact Golgi preparations from rat liver. Analysis of N-linked and O-linked glycans labeled by UDP-[6-3H]N-acetylgalactosamine. , 1993, The Journal of biological chemistry.

[18]  S. Grinstein,et al.  Dynamic measurement of the pH of the Golgi complex in living cells using retrograde transport of the verotoxin receptor , 1996, The Journal of cell biology.

[19]  M. Hollingsworth,et al.  Cloning and Characterization of a Close Homologue of Human UDP-N-acetyl-α-d-galactosamine:Polypeptide N-Acetylgalactosaminyltransferase-T3, Designated GalNAc-T6 , 1999, The Journal of Biological Chemistry.

[20]  I. Brockhausen,et al.  Mucin synthesis. UDP-GlcNAc:GalNAc-R beta 3-N-acetylglucosaminyltransferase and UDP-GlcNAc:GlcNAc beta 1-3GalNAc-R (GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase from pig and rat colon mucosa. , 1985, Biochemistry.

[21]  M. Fukuda,et al.  Molecular Cloning and Expression of a Novel β-1,6-N-Acetylglucosaminyltransferase That Forms Core 2, Core 4, and I Branches* , 1999, The Journal of Biological Chemistry.

[22]  I. Brockhausen,et al.  Synthesis of O-glycan core 3: characterization of UDP-GlcNAc: GalNAc-R beta 3-N-acetyl-glucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines. , 1995, Glycobiology.

[23]  V. Malhotra,et al.  Src Regulates Golgi Structure and KDEL Receptor-dependent Retrograde Transport to the Endoplasmic Reticulum* , 2003, Journal of Biological Chemistry.

[24]  L. Tabak,et al.  The Catalytic and Lectin Domains of UDP-GalNAc:Polypeptide α-N-Acetylgalactosaminyltransferase Function in Concert to Direct Glycosylation Site Selection* , 2008, Journal of Biological Chemistry.

[25]  D. Behar,et al.  Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis , 2004, Nature Genetics.

[26]  M. Fukuda,et al.  Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Tal Pupko,et al.  ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids , 2010, Nucleic Acids Res..

[28]  L. Tabak,et al.  Isoform-specific O-Glycosylation of Osteopontin and Bone Sialoprotein by Polypeptide N-Acetylgalactosaminyltransferase-1* , 2009, The Journal of Biological Chemistry.

[29]  S. Tsuboi,et al.  Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. , 1998, Immunity.

[30]  J. Kikuchi,et al.  Not core 2 beta 1,6-N-acetylglucosaminyltransferase-2 or -3 but -1 regulates sialyl-Lewis x expression in human precursor B cells. , 2004, Glycobiology.

[31]  T. Strom,et al.  Polypeptide GalNAc-transferase T3 and Familial Tumoral Calcinosis , 2006, Journal of Biological Chemistry.

[32]  Susumu Goto,et al.  Comprehensive analysis of glycosyltransferases in eukaryotic genomes for structural and functional characterization of glycans. , 2009, Carbohydrate research.

[33]  I. Brockhausen,et al.  Mucin‐type O‐glycans in human colon and breast cancer: glycodynamics and functions , 2006, EMBO reports.

[34]  M. Fukuda,et al.  Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. , 1988, The Journal of biological chemistry.

[35]  I. Brockhausen,et al.  A Transfected Sialyltransferase That Is Elevated in Breast Cancer and Localizes to the medial/trans-Golgi Apparatus Inhibits the Development of core-2–based O-Glycans , 1997, The Journal of cell biology.

[36]  D. Ungar.  Golgi linked protein glycosylation and associated diseases. , 2009, Seminars in cell & developmental biology.

[37]  Hiromichi Sawaki,et al.  Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10). , 2006, Journal of molecular biology.

[38]  J. Bonifacino,et al.  Mechanism of Acidification of the trans-Golgi Network (TGN) , 1998, The Journal of Biological Chemistry.

[39]  T. A. Fritz,et al.  Identification of Common and Unique Peptide Substrate Preferences for the UDP-GalNAc:Polypeptide α-N-acetylgalactosaminyltransferases T1 and T2 Derived from Oriented Random Peptide Substrates* , 2006, Journal of Biological Chemistry.

[40]  Dolores Corella,et al.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.

[41]  L. Tabak.  The role of mucin-type O-glycans in eukaryotic development. , 2010, Seminars in cell & developmental biology.

[42]  Liping Zhang,et al.  An O-Glycosyltransferase Promotes Cell Adhesion during Development by Influencing Secretion of an Extracellular Matrix Integrin Ligand* , 2010, The Journal of Biological Chemistry.

[43]  I. Brockhausen,et al.  Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells. , 1991, Cancer research.

[44]  Timothy J. Yeatman,et al.  A renaissance for SRC , 2004, Nature Reviews Cancer.

[45]  Joseph Shiloach,et al.  The beginnings of mucin biosynthesis: the crystal structure of UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase-T1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Hollingsworth,et al.  Control of O-Glycan Branch Formation , 1999, The Journal of Biological Chemistry.

[47]  R. Cummings,et al.  Protein glycosylation: Chaperone mutation in Tn syndrome , 2005, Nature.

[48]  T. Okada,et al.  Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  E. Haura,et al.  Src kinases as therapeutic targets for cancer , 2009, Nature Reviews Clinical Oncology.

[50]  F. Bard,et al.  Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes , 2010, The Journal of cell biology.

[51]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[52]  T. Samuelsson,et al.  Gel-forming mucins appeared early in metazoan evolution , 2007, Proceedings of the National Academy of Sciences.

[53]  M. Guarino.  Src signaling in cancer invasion , 2010, Journal of cellular physiology.

[54]  J. Hirabayashi,et al.  Galectin-3 Interaction with Thomsen-Friedenreich Disaccharide on Cancer-associated MUC1 Causes Increased Cancer Cell Endothelial Adhesion* , 2007, Journal of Biological Chemistry.

[55]  Michael A. Hollingsworth,et al.  Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.

[56]  M. Frame,et al.  Newest findings on the oldest oncogene; how activated src does it , 2004, Journal of Cell Science.

[57]  J. Perez-Vilar,et al.  Presence of terminal N-acetylgalactosamine residues in subregions of the endoplasmic reticulum is influenced by cell differentiation in culture. , 1991, The Journal of biological chemistry.

[58]  E. Bennett,et al.  A family of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation. , 1996, Glycobiology.

[59]  T. Irimura,et al.  The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation. , 2007, Glycobiology.

[60]  M. Jakobsen,et al.  Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family. , 1999, Glycobiology.

[61]  P. Rudd,et al.  Structural elucidation of the N- and O-glycans of human apolipoprotein(a): role of o-glycans in conferring protease resistance. , 2001, The Journal of biological chemistry.

[62]  F. Hanisch,et al.  Evidence for glycosylation-dependent activities of polypeptide N-acetylgalactosaminyltransferases rGalNAc-T2 and -T4 on mucin glycopeptides. , 2001, Glycobiology.

[63]  M. Pasumarthy,et al.  Site-specific Core 1 O-Glycosylation Pattern of the Porcine Submaxillary Gland Mucin Tandem Repeat , 1998, The Journal of Biological Chemistry.

[64]  Liping Zhang,et al.  Glycobiology on the fly: developmental and mechanistic insights from Drosophila. , 2008, Glycobiology.

[65]  I. Brockhausen,et al.  Mucin glycoproteins in neoplasia , 1996, Glycoconjugate Journal.

[66]  Ron A Wevers,et al.  Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: a review. , 2006, Clinical chemistry.

[67]  F. Mantelli,et al.  Association of Cell Surface Mucins with Galectin-3 Contributes to the Ocular Surface Epithelial Barrier* , 2009, The Journal of Biological Chemistry.

[68]  L. Tabak,et al.  Deconvoluting the functions of polypeptide N-alpha-acetylgalactosaminyltransferase family members by glycopeptide substrate profiling. , 2004, Chemistry & biology.

[69]  E. Berger,et al.  Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus. , 1998, Journal of cell science.

[70]  J. Marth,et al.  A genetic approach to Mammalian glycan function. , 2003, Annual review of biochemistry.

[71]  M. Hollingsworth,et al.  Conformational studies on the MUC1 tandem repeat glycopeptides: implication for the enzymatic O-glycosylation of the mucin protein core. , 2003, Glycobiology.

[72]  R. Dwek,et al.  Glycan structures of ocular surface mucins in man, rabbit and dog display species differences , 2008, Glycoconjugate Journal.

[73]  M. Oliveira,et al.  Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells. , 2007, Cancer letters.

[74]  R. Collins,et al.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.

[75]  J. Kihlberg,et al.  Role of the Human ST6GalNAc-I and ST6GalNAc-II in the Synthesis of the Cancer-Associated Sialyl-Tn Antigen , 2004, Cancer Research.

[76]  G. Hart,et al.  Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. , 1997, Annual review of biochemistry.

[77]  Peter Roepstorff,et al.  Functional Conservation of Subfamilies of Putative UDP-N-acetylgalactosamine:Polypeptide N-Acetylgalactosaminyltransferases inDrosophila, Caenorhabditis elegans, and Mammals , 2002, The Journal of Biological Chemistry.

[78]  M. Hollingsworth,et al.  The Lectin Domain of UDP-N-acetyl-d-galactosamine:PolypeptideN-acetylgalactosaminyltransferase-T4 Directs Its Glycopeptide Specificities* , 2000, The Journal of Biological Chemistry.

[79]  S. Hsu,et al.  C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells , 2006, Oncogene.

[80]  Richard D. Cummings,et al.  Post-translational Modifications of Recombinant P-selectin Glycoprotein Ligand-1 Required for Binding to P- and E-selectin (*) , 1996, The Journal of Biological Chemistry.

[81]  Lawrence A Tabak,et al.  Dynamic Association between the Catalytic and Lectin Domains of Human UDP-GalNAc:Polypeptide α-N-Acetylgalactosaminyltransferase-2* , 2006, Journal of Biological Chemistry.

[82]  I. Brockhausen,et al.  Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2. , 2009, Biochimica et biophysica acta.

[83]  L. Tabak,et al.  Characterization of a UDP-GalNAc:Polypeptide N-Acetylgalactosaminyltransferase That Displays Glycopeptide N-Acetylgalactosaminyltransferase Activity* , 1999, The Journal of Biological Chemistry.

[84]  J. Taylor‐Papadimitriou,et al.  The ST6GalNAc-I Sialyltransferase Localizes throughout the Golgi and Is Responsible for the Synthesis of the Tumor-associated Sialyl-Tn O-Glycan in Human Breast Cancer* , 2006, Journal of Biological Chemistry.

[85]  Lawrence A Tabak,et al.  All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. , 2003, Glycobiology.

[86]  J. Peter-Katalinic,et al.  High Density O-Glycosylation on Tandem Repeat Peptide from Secretory MUC1 of T47D Breast Cancer Cells* , 1999, The Journal of Biological Chemistry.

[87]  F. Hanisch,et al.  O-Glycosylation of the Mucin Type , 2001, Biological chemistry.

[88]  R. Haltiwanger,et al.  Role of unusual O-glycans in intercellular signaling. , 2009, The international journal of biochemistry & cell biology.

[89]  D. Kerjaschki,et al.  Altered Golgi Localization of Core 2 β-1,6-N-Acetylglucosaminyltransferase Leads to Decreased Synthesis of Branched O-Glycans* , 1997, The Journal of Biological Chemistry.

[90]  T. Irimura,et al.  N-acetylgalactosamine incorporation into a peptide containing consecutive threonine residues by UDP-N-acetyl-D-galactosaminide:polypeptide N-acetylgalactosaminyltransferases. , 2001, Glycobiology.

[91]  S. Cohen,et al.  Rescue of Drosophila Melanogaster l(2)35Aa lethality is only mediated by polypeptide GalNAc-transferase pgant35A, but not by the evolutionary conserved human ortholog GalNAc-transferase-T11 , 2010, Glycoconjugate Journal.

[92]  Henrik Clausen,et al.  Mucin-type O-glycosylation and its potential use in drug and vaccine development. , 2008, Biochimica et biophysica acta.

[93]  A. V. van Kessel,et al.  Control of O-Glycan Branch Formation , 1999, The Journal of Biological Chemistry.

[94]  Itay Mayrose,et al.  ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures , 2005, Nucleic Acids Res..

[95]  L. Tabak,et al.  Cloning and Characterization of a Ninth Member of the UDP-GalNAc:Polypeptide N-Acetylgalactosaminyltransferase Family, ppGaNTase-T9* , 2001, The Journal of Biological Chemistry.

[96]  E. Bennett,et al.  O-Glycosylation Modulates Proprotein Convertase Activation of Angiopoietin-like Protein 3 , 2010, The Journal of Biological Chemistry.

[97]  Å. Elhammer,et al.  Function of the lectin domain of polypeptide N-acetylgalactosaminyltransferase 1. , 2002, Biochemical and biophysical research communications.

[98]  A. Furlan,et al.  ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity. , 2006, Glycobiology.

[99]  G. Springer.  T and Tn, general carcinoma autoantigens. , 1984, Science.

[100]  R. Bresalier,et al.  Mucins and mucin binding proteins in colorectal cancer , 2004, Cancer and Metastasis Reviews.

[101]  S. Tsuboi,et al.  Roles of O‐linked oligosaccharides in immune responses , 2000, Bioessays.